Mounjaro may be the better choice if: You need treatment now (retatrutide is not yet available) You prefer a medication with extensive real-world safety data Your BMI qualifies you for current GLP-1 prescriptions You have type 2 diabetes (Mounjaro has robust diabetes data) You are sensitive to GI side effects and want a well-established titration protocol Your weight loss goals are achievable with 15 to 22% body weight reduction You want insurance coverage options (available for some plans) Mounjaro is the proven, accessible, right-now option
Designated as a Comprehensive Center by the American College of Surgeons, Loyola provides expert care backed by the resources of a leading academic medical institution
Scientific References Frequently Asked Questions Can I start GLP-1 therapy on any day of the week
This improvement was accompanied by substantial weight loss, alongside significant decreases in hypoxic burden, high-sensitivity C-reactive protein levels, and systolic blood pressure
Innovations include the emergence of oral GLP-1 agents, long-lasting drugs, as well as dual and triple agonists
Potassium: Essential for nerve signaling
